866-997-4948(US-Canada Toll Free)

Global Antibody Drugs Market Size, Status and Forecast 2022

Published By :

QYResearch

Published Date : Mar 2017

Category :

Healthcare

No. of Pages : 98 Pages


This report studies the global Antibody Drugs market, analyzes and researches the Antibody Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Novartis
Amgen
Bristol-Myers Squibb
F. Hoffmann-La Roche
Johnson & Johnson
AbbVie
Eli Lilly
...

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Antibody Drugs can be split into
Monoclonal Antibodies
Antibody-Drug Conjugates
Polyclonal Antibodies

Market segment by Application, Antibody Drugs can be split into
Central Nervous System (CNS) Disorders
Cancers
Autoimmune Disorders
Cardiovascular Diseases


Table of Contents

Global Antibody Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Antibody Drugs
1.1 Antibody Drugs Market Overview
1.1.1 Antibody Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Antibody Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Antibody Drugs Market by Type
1.3.1 Monoclonal Antibodies
1.3.2 Antibody-Drug Conjugates
1.3.3 Polyclonal Antibodies
1.4 Antibody Drugs Market by End Users/Application
1.4.1 Central Nervous System (CNS) Disorders
1.4.2 Cancers
1.4.3 Autoimmune Disorders
1.4.4 Cardiovascular Diseases

2 Global Antibody Drugs Competition Analysis by Players
2.1 Antibody Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Novartis
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Antibody Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Amgen
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Antibody Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Bristol-Myers Squibb
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Antibody Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 F. Hoffmann-La Roche
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Antibody Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Johnson & Johnson
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Antibody Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 AbbVie
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Antibody Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Eli Lilly
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Antibody Drugs Revenue (Value) (2012-2017)
3.7.5 Recent Developments

4 Global Antibody Drugs Market Size by Type and Application (2012-2017)
4.1 Global Antibody Drugs Market Size by Type (2012-2017)
4.2 Global Antibody Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Antibody Drugs in Future
4.4 Top Consumer/End Users of Antibody Drugs

5 United States Antibody Drugs Development Status and Outlook
5.1 United States Antibody Drugs Market Size (2012-2017)
5.2 United States Antibody Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU Antibody Drugs Development Status and Outlook
6.1 EU Antibody Drugs Market Size (2012-2017)
6.2 EU Antibody Drugs Market Size and Market Share by Players (2016 and 2017)

7 Japan Antibody Drugs Development Status and Outlook
7.1 Japan Antibody Drugs Market Size (2012-2017)
7.2 Japan Antibody Drugs Market Size and Market Share by Players (2016 and 2017)

8 China Antibody Drugs Development Status and Outlook
8.1 China Antibody Drugs Market Size (2012-2017)
8.2 China Antibody Drugs Market Size and Market Share by Players (2016 and 2017)

9 India Antibody Drugs Development Status and Outlook
9.1 India Antibody Drugs Market Size (2012-2017)
9.2 India Antibody Drugs Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Antibody Drugs Development Status and Outlook
10.1 Southeast Asia Antibody Drugs Market Size (2012-2017)
10.2 Southeast Asia Antibody Drugs Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Antibody Drugs Market Size (Value) by Regions (2017-2022)
11.1.1 United States Antibody Drugs Revenue and Growth Rate (2017-2022)
11.1.2 EU Antibody Drugs Revenue and Growth Rate (2017-2022)
11.1.3 Japan Antibody Drugs Revenue and Growth Rate (2017-2022)
11.1.4 China Antibody Drugs Revenue and Growth Rate (2017-2022)
11.1.5 India Antibody Drugs Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Antibody Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Antibody Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Antibody Drugs Market Size by Application (2017-2022)

12 Antibody Drugs Market Dynamics
12.1 Antibody Drugs Market Opportunities
12.2 Antibody Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Antibody Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Antibody Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Antibody Drugs Product Scope
Figure Global Antibody Drugs Market Size (Million USD) (2012-2017)
Table Global Antibody Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Antibody Drugs Market Share by Regions in 2016
Figure United States Antibody Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Antibody Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Antibody Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Antibody Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Antibody Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Antibody Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Antibody Drugs Market Share by Type in 2016
Figure Monoclonal Antibodies Market Size (Million USD) and Growth Rate (2012-2017)
Figure Antibody-Drug Conjugates Market Size (Million USD) and Growth Rate (2012-2017)
Figure Polyclonal Antibodies Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Antibody Drugs Market Share by Application in 2016
Figure Antibody Drugs Market Size (Million USD) and Growth Rate in Central Nervous System (CNS) Disorders (2012-2017)
Figure Antibody Drugs Market Size (Million USD) and Growth Rate in Cancers (2012-2017)
Figure Antibody Drugs Market Size (Million USD) and Growth Rate in Autoimmune Disorders (2012-2017)
Figure Antibody Drugs Market Size (Million USD) and Growth Rate in Cardiovascular Diseases (2012-2017)
Table Antibody Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Antibody Drugs Market Size Share by Players in 2016
Figure Antibody Drugs Market Size Share by Players in 2017
Table Novartis Basic Information List
Table Antibody Drugs Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Antibody Drugs Business Revenue Market Share in 2016
Table Amgen Basic Information List
Table Antibody Drugs Business Revenue (Million USD) of Amgen (2012-2017)
Figure Amgen Antibody Drugs Business Revenue Market Share in 2016
Table Bristol-Myers Squibb Basic Information List
Table Antibody Drugs Business Revenue (Million USD) of Bristol-Myers Squibb (2012-2017)
Figure Bristol-Myers Squibb Antibody Drugs Business Revenue Market Share in 2016
Table F. Hoffmann-La Roche Basic Information List
Table Antibody Drugs Business Revenue (Million USD) of F. Hoffmann-La Roche (2012-2017)
Figure F. Hoffmann-La Roche Antibody Drugs Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Antibody Drugs Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Antibody Drugs Business Revenue Market Share in 2016
Table AbbVie Basic Information List
Table Antibody Drugs Business Revenue (Million USD) of AbbVie (2012-2017)
Figure AbbVie Antibody Drugs Business Revenue Market Share in 2016
Table Eli Lilly Basic Information List
Table Antibody Drugs Business Revenue (Million USD) of Eli Lilly (2012-2017)
Figure Eli Lilly Antibody Drugs Business Revenue Market Share in 2016
Table Global Antibody Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Antibody Drugs Market Size Share by Type in 2012
Figure Global Antibody Drugs Market Size Share by Type in 2013
Figure Global Antibody Drugs Market Size Share by Type in 2014
Figure Global Antibody Drugs Market Size Share by Type in 2015
Figure Global Antibody Drugs Market Size Share by Type in 2016
Figure Global Antibody Drugs Market Size Share by Type in 2017
Table Global Antibody Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Antibody Drugs Market Size (Million USD) by Application in 2012
Figure Global Antibody Drugs Market Size (Million USD) by Application in 2013
Figure Global Antibody Drugs Market Size (Million USD) by Application in 2014
Figure Global Antibody Drugs Market Size (Million USD) by Application in 2015
Figure Global Antibody Drugs Market Size (Million USD) by Application in 2016
Figure Global Antibody Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Antibody Drugs
Figure United States Antibody Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Antibody Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Antibody Drugs Market Size Share by Players in 2016
Figure United States Antibody Drugs Market Size Share by Players in 2017
Figure EU Antibody Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Antibody Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Antibody Drugs Market Size Share by Players in 2016
Figure EU Antibody Drugs Market Size Share by Players in 2017
Figure Japan Antibody Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Antibody Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Antibody Drugs Market Size Share by Players in 2016
Figure Japan Antibody Drugs Market Size Share by Players in 2017
Figure China Antibody Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Antibody Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Antibody Drugs Market Size Share by Players in 2016
Figure China Antibody Drugs Market Size Share by Players in 2017
Figure India Antibody Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Antibody Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Antibody Drugs Market Size Share by Players in 2016
Figure India Antibody Drugs Market Size Share by Players in 2017
Figure Southeast Asia Antibody Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Antibody Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Antibody Drugs Market Size Share by Players in 2016
Figure Southeast Asia Antibody Drugs Market Size Share by Players in 2017
Figure Global Antibody Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Antibody Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Antibody Drugs Market Size Share by Regions in 2017
Figure Global Antibody Drugs Market Size Share by Regions in 2022
Figure United States Antibody Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Antibody Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Antibody Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Antibody Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Antibody Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Antibody Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Antibody Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Antibody Drugs Market Size Share by Type in 2017
Figure Global Antibody Drugs Market Size Share by Type in 2022
Table Global Antibody Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Antibody Drugs Market Size (Million USD) by Application in 2017
Figure Global Antibody Drugs Market Size (Million USD) by Application in 2022

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *